Cyramza
Ramucirumab · VEGF / VEGFR-2 Angiogenesis Inhibitor
Indications & Uses
Colorectal Cancer, Non-Small Cell Lung Cancer, Glioblastoma, Renal Cell Carcinoma, Gastric Cancer, and Ovarian Cancer.
Contraindications
Hypersensitivity to active ingredient or any formulation excipients.
Side Effects & Warnings
Hypertension, proteinuria, gastrointestinal perforation, impaired wound healing, hemorrhage, arterial thromboembolism.
Drug & Dietary Interactions
Caution with strong CYP3A inhibitors or inducers; review concurrent medications.
For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.
Patient & Caregiver Support
Ask About This Medication
Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.